本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cue Biopharma, Inc.

0.8829
-0.0221-2.44%
盘后0.88290.00000.00%19:46 EDT
成交量:17.74万
成交额:15.59万
市值:6,652.64万
市盈率:-1.36
高:0.9200
开:0.8900
低:0.8500
收:0.9050
数据加载中...
2022/11/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/15

重要事件披露

8-K - Current report
2022/11/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/22

重要事件披露

8-K - Current report
2022/06/10

重要事件披露

8-K - Current report
2022/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/30

重要事件披露

8-K - Current report
2022/03/16

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/16

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/18

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/17

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/15

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/08

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/08

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]